Navigation Links
Harmful chemicals change the genetic response to hormone estrogen,,,,

The drug diethylstilbestrol (DES) may lead to different genetic response// to the female hormone estrogen, when exposed to it early in life.

The drug DES was prescribed to women for prevention of miscarriages, from the year 1938 to 1971. Research says that daughters of women who had used the drug are at increased risk from reproductive tract abnormalities, ectopic pregnancy, pre-term delivery, infertility, and rare form of vaginal and cervical cancer called clear-cell adenocarcinoma. These women may also be at increased risk from tumor of the uterus.

Previously it was held that the harmful ingredients of the environment only cause genetic changes. The research brings into light the way genetic changes happen in an individual from harmful drugs while still in the womb of the mother.

Researchers feel that the study shows how environmental changes along with changed genetic responses increase the risk of cancer. The study in this regard may help the medical practioners to understand which patients are more likely to be at a high risk from cancer, and also to take a look into their medical histories even before birth.

The research report came out in the May edition of Proceedings of the National Academy of Sciences.
'"/>




Page: 1

Related medicine news :

1. More Elderly Take Inappropriate and Harmful Medications
2. Healthy Medicine Or Harmful Intoxicant?
3. Antidepressants Harmful for Kids
4. The Harmful Effects Of Cigarette Smoke
5. Antidepressants Late In Pregnancy Harmful to Unborn Baby
6. The Harmful Effects Of Stress in Young Adults
7. Yet Another Harmful Consequence Of Smoking
8. Understanding The Harmful Effects Of Radiation Exposure
9. The Harmful Effects Of Secondhand Smoke
10. Intake of Vitamin E Supplements During Pregnancy May be Harmful
11. Light & Mild Cigarettes Just As Harmful As Regular Ones
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a ... of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners ... October 11, 2017. , The annual award competition recognizes editorial and design excellence across ...
(Date:10/12/2017)... ... 12, 2017 , ... On Saturday, October 21, the Health & Wellness Center ... to raise money for the American Heart Association Heart Walk. Teams of up to ... together to keep their treadmills moving for 5 hours. Treadmills will start at 7:00 ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations ... literacy software tool, and the Cancer Patient Education Network (CPEN), an independent professional ... announce a new strategic alliance. , As CPEN’s strategic partner, HLI will ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... ... presenting the latest in wound care advancements to physician colleagues, skilled nursing facility ... is titled, "Navigating the Treacherous Waters of Wound Care." , "At many of ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... its enhanced Pepper Flow promotional review platform at the Promotional Review Committee ... insight-driven capabilities help marketers streamline the medical, legal, and regulatory review (MLR) ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... PHILADELPHIA , Oct. 2, 2017 Halo Labs announces ... particle analysis system called the HORIZON at MIBio 2017 in ... analyzes subvisible and visible particulate matter in biopharmaceutical samples with unprecedented ... use of the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: